Welcome to the CDC Chronic Fatigue Syndrome site.
Skip directly to the search box, site navigation, or content.
News & Highlights
- New Publication Linking Sexual Abuse and CFS -- NEW!
- New Publication: 1994 CFS Case Definition Criteria Validated -- NEW!
CFS Research Program, External Peer Review (PDF – 46KB)- Current CDC Research
- CME Course
- Chronic Fatigue Registry
- Treatment Guidelines
- Brochures
- Glossary
- more...
- Mission/Goals
- Public Service Announcements
- Brochures
- Photo Exhibit
CFS Awareness
Campaign
Call to Action - Act Now
| Paid for by | |
| HHS | CDC |
 |
 |
Meetings and Workshops: February 23-26, 2003
During February 23-26, 2003, the Centers for Disease Control and Prevention (CDC) and the CFIDS Association of America cosponsored a meeting, Towards Understanding of Cellular and Molecular Mechanisms of Medically Unexplained Fatigue, at the Banbury Center, Cold Spring Harbor Laboratory, New York.
The objective of the meeting was to identify gaps in current approaches to the study of medically unexplained fatigue. In particular, will further progress require paradigm shifts, new technologies, or simply more work in currently established directions?
The first morning focused on chronic fatigue and the state of the science. Presentations and discussion reviewed the spectrum of ailments in medically unexplained fatiguing illnesses, the magnitude of medically unexplained fatigue as a public health problem, cognitive behavioral and emotional factors in chronic fatigue, neuroendocrine perturbations in chronic fatigue, and acute infection-immunologic perturbations and chronic fatigue. The afternoon session was concerned with influences on the structure and function of the brain. Presentations covered the relevance of cerebral perfusion and neurometabolic-synaptic activity to CFS, regulation of the neurohypophyseal system, communication between the brain and the immune system, and immunologic stress, the brain, and CFS.
The second day began with a session on infection, immunity, sex, and the brain. There were presentations and discussion concerning neuroendocrine regulation of immunity, maternal infection, fetal brain development and health, chronic consequences of persistent infection, and immunity. This was followed by a series of talks and discussion on analytical approaches searching for markers applicable to medically unexplained fatigue. This encompassed what psychopharmacology tells us about the pathophysiology of medically unexplained fatigue, biomarker discovery in illness with no lesion, sex (male vs. female) as a determinant of disease, and microchimerism.
The third day involved discussion of presentations and preparation of a report on future research directions to better understand the cellular and molecular mechanisms of medically unexplained fatigue.
Meeting Participants
Invited participants included:
- Jack C. de la Torre (University of California, San Diego, CA)
- Birgitta Evengard (Karolinska Institute, Stockholm, Sweden)
- Carol M. Artlett (Thomas Jefferson University, Philadelphia, PA)
- Anthony J Cleare (Guy's King's and St Thomas' School of Medicine, London, UK)
- Mary Ann Fletcher (University of Miami School of Medicine, Miami, FL)
- Eleanor Hanna (National Institutes of Health, Bethesda, MD)
- Leonard A. Jason (DePaul University, Chicago, IL)
- Kevin D. Karem (CDC, Atlanta, GA)
- Andrew Lloyd (University of New south Wales, Sydney, Australia)
- Ian Hickie (St George Hospital, Sydney, Australia)
- James F. Jones (National Jewish Medical and Research Center, Denver, CO)
- Kimberly Kenney (CFIDS Association of America, Charlotte, NV)
- Steven F. Maier, University of Colorado, Boulder, CO)
- Andrew H. Miller (Emory University, Atlanta, GA)
- Rosane Nisenbaum (CDC, Atlanta, GA)
- Paul H. Patterson (California Institute of Technology, Pasadena, CA)
- Mangalathu Rajeevan (CDC, Atlanta, GA)
- Sharon Shriver (Penn State University, University Park, PA)
- Esther M. Sternberg (National Institutes of Health, Bethesda, MD)
- Dimitris Papanicolaou (Emory University, Atlanta, GA)
- Charles L. Raison (Emory University, Atlanta, GA)
- William C. Reeves (CDC, Atlanta, GA)
- Celia D. Sladek (University of Colorado Health Sciences Center, Denver, CO)
- Elizabeth R. Unger (CDC, Atlanta, GA)
- Suzanne Vernon (CDC, Atlanta, GA)
- Simon Wessely (Institute of Psychiatry, London, UK)
- Peter D. White (St. Bartholomew's Hospital, London, UK)
- Ute Vollmer-Conna (University of New South Wales, Sydney, Australia)
- Toni Whistler (CDC, Atlanta, GA)
Page last modified on May 8, 2006
Additional Navigation for the CDC Website
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
Tel: 404-639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435